KINNATE BIOPHARMA INC - COM (KNTE)

Historical Portfolio Holders from Q4 2020 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 0 $0 -$92.1M 0
2024 Q1 34.6M $92.1M -$8.96M $2.66 53
2023 Q4 38.4M $91M +$3.74M $2.37 61
2023 Q3 38.6M $54M -$5.57M $1.40 55
2023 Q2 40.1M $121M -$32.3M $3.03 70
2023 Q1 43.3M $270M +$15.3M $6.25 70
2022 Q4 40.8M $249M -$18.3M $6.10 78
2022 Q3 43.6M $521M +$5.41M $11.95 81
2022 Q2 43.1M $544M +$23.6M $12.61 70
2022 Q1 41.3M $465M -$24.8M $11.26 75
2021 Q4 42.4M $751M -$6.15M $17.72 69
2021 Q3 36.6M $842M +$23.5M $23.02 70
2021 Q2 38.3M $891M +$7.68M $23.28 61
2021 Q1 35.1M $1.09B +$51.8M $31.16 61
2020 Q4 33.3M $1.32B +$1.28B $39.78 54